A Tribute to Paul Greengard (1925-2019): Advances in Pharmacology, cartea 90
Stevin H. Zornen Limba Engleză Hardback – 2 mar 2021
- Includes the authority and expertise of leading contributors in pharmacology
- Presents the latest release in the Advances in Pharmacology series
Din seria Advances in Pharmacology
- 25% Preț: 1068.91 lei
- 5% Preț: 542.15 lei
- 5% Preț: 551.83 lei
- 5% Preț: 543.41 lei
- 23% Preț: 438.81 lei
- 5% Preț: 560.62 lei
- 5% Preț: 1923.04 lei
- 5% Preț: 1922.16 lei
- 5% Preț: 1930.54 lei
- 29% Preț: 1004.67 lei
- 29% Preț: 1131.29 lei
- 27% Preț: 1486.29 lei
- 27% Preț: 1480.25 lei
- 5% Preț: 1827.70 lei
- 5% Preț: 1837.16 lei
- 5% Preț: 1825.12 lei
- 5% Preț: 1826.93 lei
- 5% Preț: 1830.95 lei
- 5% Preț: 1841.19 lei
- 29% Preț: 1073.49 lei
- 29% Preț: 1079.06 lei
- 32% Preț: 1026.57 lei
- 29% Preț: 1078.00 lei
- 29% Preț: 1075.75 lei
- 32% Preț: 1030.88 lei
- 9% Preț: 1032.61 lei
- 29% Preț: 1072.97 lei
- 29% Preț: 1078.38 lei
- 29% Preț: 1074.03 lei
- 29% Preț: 1073.22 lei
- 25% Preț: 1070.78 lei
- 29% Preț: 1071.06 lei
- 29% Preț: 1071.78 lei
- 24% Preț: 1150.43 lei
- 24% Preț: 1149.55 lei
- 31% Preț: 1151.52 lei
- 15% Preț: 1209.67 lei
- 15% Preț: 1215.63 lei
- 25% Preț: 1075.40 lei
- 25% Preț: 1074.41 lei
- 25% Preț: 1074.83 lei
- 25% Preț: 1073.42 lei
Preț: 1072.05 lei
Preț vechi: 1428.91 lei
-25% Nou
Puncte Express: 1608
Preț estimativ în valută:
205.19€ • 211.46$ • 173.23£
205.19€ • 211.46$ • 173.23£
Carte tipărită la comandă
Livrare economică 22 februarie-08 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128225165
ISBN-10: 0128225165
Pagini: 326
Dimensiuni: 152 x 229 mm
Greutate: 0.61 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Pharmacology
ISBN-10: 0128225165
Pagini: 326
Dimensiuni: 152 x 229 mm
Greutate: 0.61 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Pharmacology
Public țintă
investigators in neuroscience, pharmacology, neurology, psychiatry, medicine.Cuprins
1. Paul Greengard: A persistent desire to comprehend the brain, and also to fix it
Marc Flajolet, Thu Lan N-Guyen, Vijay Kumar Siripuram and Yashoda Krishna Sunkari
2. Giving names to the actors of synaptic transmission: The long journey from synaptic vesicles to neural plasticity
Fabio Benfenati, Martin Bähler and Flavia Valtorta
3. cAMP-regulated phosphoproteins DARPP-32, ARPP16/19, and RCS modulate striatal signal transduction through protein kinases and phosphatases
Kyle R. Christensen and Angus C. Nairn
4. DARPP-32 40 years later
Jean-Antoine Girault and Angus C. Nairn
5. Effects of nicotine on DARPP-32 and CaMKII signaling relevant to addiction
Angela M. Lee and Marina R. Picciotto
6. Modulation of dendritic spines by protein phosphatase-1
Jimcy Platholi and Hugh C. Hemmings Jr
7. Deciphering cell-type specific signal transduction in the brain: Challenges and promises
Jean-Pierre Roussarie and Patricia Rodriguez-Rodriguez
8. Drug-activated cells: From immediate early genes to neuronal ensembles in addiction
Marine Salery, Arthur Godino and Eric J. Nestler
9. NAPE-specific phospholipase D regulates LRRK2 association with neuronal membranes
Francesca Palese, Silvia Pontis, Natalia Realini and Daniele Piomelli
10. Amyloidogenic and anti-amyloidogenic properties of presenilin 1
Victor Bustos, Maria Pulina and Jose Ledo
11. A review of the pharmacology and clinical profile of lumateperone for the treatment of schizophrenia
Gretchen L Snyder, Kimberly E Vanover, Robert E Davis, Peng Li, Allen Fienberg and Sharon Mates
12. Uniting homeostatic plasticity and exosome biology: A revision of the conceptual framework for drug discovery in neurodegenerative diseases?
James K.T. Wang
Marc Flajolet, Thu Lan N-Guyen, Vijay Kumar Siripuram and Yashoda Krishna Sunkari
2. Giving names to the actors of synaptic transmission: The long journey from synaptic vesicles to neural plasticity
Fabio Benfenati, Martin Bähler and Flavia Valtorta
3. cAMP-regulated phosphoproteins DARPP-32, ARPP16/19, and RCS modulate striatal signal transduction through protein kinases and phosphatases
Kyle R. Christensen and Angus C. Nairn
4. DARPP-32 40 years later
Jean-Antoine Girault and Angus C. Nairn
5. Effects of nicotine on DARPP-32 and CaMKII signaling relevant to addiction
Angela M. Lee and Marina R. Picciotto
6. Modulation of dendritic spines by protein phosphatase-1
Jimcy Platholi and Hugh C. Hemmings Jr
7. Deciphering cell-type specific signal transduction in the brain: Challenges and promises
Jean-Pierre Roussarie and Patricia Rodriguez-Rodriguez
8. Drug-activated cells: From immediate early genes to neuronal ensembles in addiction
Marine Salery, Arthur Godino and Eric J. Nestler
9. NAPE-specific phospholipase D regulates LRRK2 association with neuronal membranes
Francesca Palese, Silvia Pontis, Natalia Realini and Daniele Piomelli
10. Amyloidogenic and anti-amyloidogenic properties of presenilin 1
Victor Bustos, Maria Pulina and Jose Ledo
11. A review of the pharmacology and clinical profile of lumateperone for the treatment of schizophrenia
Gretchen L Snyder, Kimberly E Vanover, Robert E Davis, Peng Li, Allen Fienberg and Sharon Mates
12. Uniting homeostatic plasticity and exosome biology: A revision of the conceptual framework for drug discovery in neurodegenerative diseases?
James K.T. Wang